GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Price-to-Owner-Earnings

PharmaRoth Labs (PharmaRoth Labs) Price-to-Owner-Earnings : (As of May. 21, 2024)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Price-to-Owner-Earnings?

As of today (2024-05-21), PharmaRoth Labs's share price is $0.0001. PharmaRoth Labs does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for PharmaRoth Labs's Price-to-Owner-Earnings or its related term are showing as below:


ROTH's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.465
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-21), PharmaRoth Labs's share price is $0.0001. PharmaRoth Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.00. Therefore, PharmaRoth Labs's PE Ratio for today is At Loss.

As of today (2024-05-21), PharmaRoth Labs's share price is $0.0001. PharmaRoth Labs's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.00. Therefore, PharmaRoth Labs's PE Ratio without NRI for today is At Loss.


PharmaRoth Labs Price-to-Owner-Earnings Historical Data

The historical data trend for PharmaRoth Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Price-to-Owner-Earnings Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Price-to-Owner-Earnings
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaRoth Labs's Price-to-Owner-Earnings

For the Biotechnology subindustry, PharmaRoth Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Price-to-Owner-Earnings falls into.



PharmaRoth Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PharmaRoth Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0001/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaRoth Labs  (GREY:ROTH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PharmaRoth Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines